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Abstract 
DNA methylation is one of the main epigenetic modifications in the eukaryotic genome and has 
been shown to play a role in cell-type specific regulation of gene expression, and therefore 
cell-type identity.  Bisulfite sequencing is the gold-standard for measuring methylation over the 
genomes of interest. Here, we review several techniques used for the analysis of 
high-throughput bisulfite sequencing. We introduce specialized short-read alignment techniques 
as well as pre/post-alignment quality check methods to ensure data quality. Furthermore, we 
discuss subsequent analysis steps after alignment.  We introduce various differential 
methylation methods and compare their performance using simulated and real 
bisulfite-sequencing datasets. We also discuss the methods used to segment methylomes in 
order to pinpoint regulatory regions. We introduce annotation methods that can be used further 
classification of regions returned by segmentation or differential methylation methods. Lastly, we 
review software packages that implement strategies to efficiently deal with large bisulfite 
sequencing datasets locally and also discuss online analysis workflows that do not require any 
prior programming skills. The analysis strategies described in this review will guide researchers 
at any level to the best practices of bisulfite-sequencing analysis. 
Introduction 
Cytosine methylation (5-methylcytosine, 5mC) is one of the main covalent base modifications in 
eukaryotic genomes. It is involved in epigenetic regulation of gene expression in a cell type 
specific manner. It can be added or removed and can remain stable throughout cell division. 
Classical understanding of DNA methylation is that it silences gene expression when occurs at 
a CpG rich promoter region ​[1]​. It occurs predominantly on CpG dinucleotides and seldom on 
 
 
 
 
 
. CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/109512doi: bioRxiv preprint first posted online Feb. 17, 2017; 
non-CpG bases in metazoan genomes. The non-CpG methylation has been mainly observed in 
human embryonic stem and neuronal cells ​[2]​,​[3]​. There are roughly 28 million CpGs in the 
human genome, 60–80% are generally methylated. Less than 10% of CpGs occur in CG-dense 
regions that are termed CpG islands in the human genome ​[4]​. It has been demonstrated that 
DNA methylation is also not uniformly distributed over the genome and associated with CpG 
density. In vertebrate genomes, the cytosines are usually unmethylated in CpG-rich regions 
such as CpG islands and methylated in CpG-deficient regions. The vertebrate genomes are 
largely CpG deficient except at CpG islands. On the contrary, invertebrates such as ​Drosophila 
melanogaster​  and ​Caenorhabditis elegans​  do not have cytosine methylation and associated 
with this feature, they do not have CpG rich and poor regions but rather a steady CpG 
frequency over the genome ​[5]​.​ DNA methylation is established by DNA methyltransferases 
DNMT3A and DNMT3B in combination with DNMT3L and maintained through/after cell division 
by the methyltransferase DNMT1 and associated proteins. DNMT3a and DNMT3b are in charge 
of the de novo methylation during early development. Loss of 5mC can be achieved passively 
by dilution during replication or exclusion of DNMT1 from the nucleus. Recent discoveries of 
ten-eleven translocation (TET) family of proteins and their ability to convert 5-methylcytosine 
(5mC) into 5-hydroxymethylcytosine (5-hmC) in vertebrates provide a path for catalysed active 
DNA demethylation ​[6]​. Iterative oxidations of 5-hmC catalysed by TET result in 
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 5caC mark is excised from DNA​ ​by G/T 
mismatch-specific thymine-DNA glycosylase (TDG), which as a result returns cytosine residue 
back to its unmodified state​ ​[7]​. Apart from these, mainly bacteria but possibly higher eukaryotes 
contain base modifications on other bases than cytosine, such as ​methylated adenine or 
guanine ​[8]​. 
 
One of the most reliable and popular ways to measure DNA methylation is bisulfite sequencing. 
These and related methods allow measuring DNA methylation at the single nucleotide 
resolution. In this review, we will describe strategies for analyzing data from bisulfite sequencing 
experiments. First, we will introduce high-throughput sequencing techniques based on bisulfite 
treatment. Next, we summarize algorithms and tools for detecting differential methylation and 
methylation profile segmentation. Lastly, we will discuss how to deal with large datasets and 
data analysis workflows with guided user interface. The computational workflow summarizing all 
the necessary steps is shown in Figure 1.  
 
Bisulfite sequencing for detection of methylation and other base modifications 
Approaches that enable profiling genome-wide DNA methylation fall into four categories: 
methods based on restriction enzymes sensitive to DNA methylation (such as MRE-seq), 
methylcytosine-specific antibodies (such as methylated DNA immunoprecipitation (MeDIP ​[9]​), 
methyl-CpG-binding domains to enrich for methylated DNA at sites of interest ​[10]​ and those 
based on sodium bisulfite treatment. However, the first three methods allow to detect 
methylation over measured regions ranging in size from 100 to 1000 bp. Methods that use 
sodium bisulfite treatment, which converts unmethylated cytosines to thymine (via uracil) while 
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methylated cytosines remain protected, measure DNA methylation at single nucleotide 
resolution ​[11]​. For the remainder of this section, we will focus on bisulfite-conversion based 
sequencing techniques. 
 
The whole genome bisulfite sequencing (WGBS) is considered as the ‘gold standard’ for DNA 
methylation measurement due to whole-genome coverage and the single-base resolution. 
Briefly, it combines bisulfite conversion of DNA molecules with high-throughput sequencing. To 
perform WGBS, the genomic DNA is first randomly fragmented to desired size (200 bp). The 
fragmented DNA is converted into a sequencing library by ligation to adaptors that contain 
5-mCs. The sequence library is then treated with bisulfite. This treatment effectively converts 
unmethylated cytosines to uracil. After amplifying the library treated with bisulfite by PCR, it is 
sequenced using high-throughput sequencing. After the PCR, uracils will be represented as 
thymines. A precise recall of cytosine methylation does not only require sufficient sequencing 
depth but also strongly depends on the quality of bisulfite conversion and library amplification. 
The benefits of this shotgun approach is that it typically reaches a coverage >90% of the CpGs 
in the human genome in unbiased representation. It allows identification of non-CG methylation 
as well as identification of partially methylated domains (PMDs, ​[2]​), low methylated regions at 
distal regulatory elements (LMRs, ​[12]​) and DNA methylation valleys (DMVs) in embryonic stem 
cells ​[13]​. Despite its advantages, WGBS remains the most expensive technique and usually is 
not applied to large number of samples and requires relatively large quantities of DNA (100ng–5 
ug) ​[14]​. To achieve high sensitivity of detecting methylation differences between samples, high 
sequencing depth is required which leads to significant increase in sequencing cost.  
 
The reduced representation bisulfite sequencing (RRBS) is another technique, which can also 
profile DNA methylation at single-base resolution. It combines digestion of genomic DNA with 
restriction enzymes and sequencing with bisulfite treatment in order to enrich for areas with a 
high CpG content. Therefore it relies first on digestion of genomic DNA with restriction enzymes, 
such as MspI which recognises 5’-CCGG-3’ sequences and cleaves the phosphodiester bonds 
upstream of CpG dinucleotide. It can sequence only CpG dense regions and doesn’t interrogate 
CpG-deficient regions such as functional enhancers, intronic regions, intergenic regions or in 
general lowly methylated regions of the genome. It has limited coverage of the genome in CpG 
poor regions and examines about 4% to 17% of the approximately 28 million CpG dinucleotides 
distributed throughout the human genome depending on the sequencing depth and which 
variant of RRBS is used ​[15,16]​. 
 
Targeted Bisulfite sequencing also uses a combination of bisulfite sequencing with 
high-throughput sequencing, but it needs a prior selection of predefined genomic regions of 
interest. Frequently used protocols employ either PCR amplification of regions of interest 
[17,18]​, padlock probes ​[19]​, or hybridization-based target enrichment ​[20]​. 
 
One of the major assay specific issues is the fact that bisulfite sequencing can not discriminate 
between hydroxymethylation (5-hmC) and methylation (5-mC) ​[21]​. Hydroxymethylation 
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converts to cyto-5-methanesulfonate upon bisulfite treatment, which then reads as a C when 
sequenced ​[21]​. Furthermore, 5-hmC mediated by TET proteins is a mechanism of non-passive 
DNA demethylation. Therefore, methylation measurements for tissues having high 
5-hydroxymethylation will not be reliable at least in certain genomic regions. The development 
of Tet-assisted bisulfite sequencing (TAB-seq) ​[22]​ and oxBS-Seq ​[23]​ enabled to distinguish 
between the two modifications at single base resolution. In addition to 5-hmC, single-base 
resolution mapping of 5caC using CAB-seq ​[24]​ and detection of 5fc (fCAB-seq ​[25,26]​ and 
redBS-Seq ​[25,26]​) in mammalian genomes has recently been achieved.  
Alignment and data processing for bisulfite sequencing 
Since BS-seq changes unmethylated cytosines (C) to thymines (T), subsequent steps for 
analysis aim for counting the number of C to T conversions and quantifying the methylation 
proportion per base. This is simply done by identifying C-to-T conversions in the aligned reads 
and dividing number of Cs by the sum of Ts and Cs for each cytosine in the genome. Being able 
to do the quantification reliably depends on quality control before alignment, the alignment 
methods and post-alignment quality control.  
 
Since base-calling quality is not constant and could change between sequencing runs and 
within the same read, it is important to check the base quality, which represents the level of 
confidence in the base calls. Miscalled bases can be counted as C-T conversions erroneously. 
If possible such errors should be avoided. This basic quality check can be done via fastQC 
software (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). In addition, sometimes 
adapters can be sequenced and if not properly removed they will either lower the alignment 
rates or can cause false C-T conversions. We recommend trimming low quality bases on 
sequence ends and removing adapters to minimize issues with false C-T conversions and 
increasing the alignment rates. This can be achieved using trimming programs such as Trim 
Galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/).  
 
Once pre-alignment quality control and processing is done, the next step is the alignment where 
the algorithms should be able to deal with potential C-T conversions. The BS-seq alignment 
methods mostly rely on modifications of known short-read alignment methods. For example, 
Bismark relies on Bowtie and in silico C-T conversion of reads and genomes ​[27]​. Many other 
aligners use this in silico conversion strategy, such as: MethylCoder ​[28]​, BS-seeker2 ​[29]​, 
BRAT-BW ​[30]​ and Bison ​[31]​. Other methods, such as Last ​[32]​, uses a specific score matrix 
that can tolerate C-T mismatches or ,such as BSMAP ​[33]​ , masks Ts in the reads and matches 
them to genomic Cs. There are not many comprehensive benchmarks of the aligners since 
there is a new one coming frequently, but earlier attempts to compare the performance of the 
aligners did not find intolerable differences between aligners ​[34,35]​. In addition, tool developers 
usually spend more time optimizing their tool for the benchmark than optimizing the competing 
tools when preparing publications. For us, there is no compelling evidence that an established 
tool such as Bismark is significantly worse or better in accuracy than the competing tools. For 
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our own work, we frequently use Bismark since it provides BAM files, as well as additional 
methylation call related metrics and files.  
 
After the alignment and methylation calling, there is still a need for further quality control. One of 
the potential problems with bisulfite sequencing is incomplete conversion, where not all 
unmethylated Cs are converted to Ts. Incomplete conversion causes false positives results due 
to interpretation of the unconverted unmethylated cytosines as methylated. For species without 
major non-CpG methylation, such as human, we can calculate the conversion rate by using the 
percentage of non-CpG methylation. For a high quality experiment, we expect the conversion 
rate to be as close to 100% as possible, typical values for a good experiment will be higher than 
99.5%. Another way to measure conversion rate is to add spike-in sequences with 
unmethylated Cs and counting the number of Ts for unmethylated Cs. Degradation of DNA 
during bisulfite treatment is another potential problem. Long incubation time and high bisulfite 
concentration, can lead to the degradation of about 90% of the incubated DNA ​[36]​. Therefore, it 
is crucial to check unique alignment rates and read lengths after trimming. Other post-alignment 
quality metrics include removing known C/T SNPs which can interfere with methylation calls. 
The last post-alignment quality procedure is to deal with PCR bias. A simple way could be to 
remove reads that align to the exact same genomic position on the same strand. This 
de-duplication can be performed using the “samtools rmdup” command or Bismark tools. For 
RRBS, due to experimental procedures removing PCR duplicates by looking at overlapping 
coordinates of reads is not advised. Instead, one can try to remove PCR bias by removing 
regions with unusually high coverage, this method produces concurrent methylation 
measurements with orthogonal methods such as pyrosequecing ​[37]​.  
 
Differential methylation methods 
Once we have methylation proportions per base, we would generally proceed to discover the 
dynamics of methylation profiles. When there are multiple sample groups, it is usually of interest 
to locate bases or regions with different methylation proportions across samples. These bases 
or regions with different methylation proportions across samples are called differentially 
methylated CpG sites (DMCs) and differentially methylated regions (DMRs). They have been 
shown to play a role in many different diseases due to their association to epigenetic control of 
gene regulation. In addition, DNA methylation profiles can be highly tissue-specific due to their 
involvement in gene regulation ​[38]​. DNA methylation is highly informative when studying 
normal and diseased cells, because it can also act as a biomarker ​[39]​. For example, the 
presence of large-scale abnormally methylated genomic regions is a hallmark feature of many 
types of cancers ​[40]​. Because of aforementioned reasons, investigating differential methylation 
is  usually one of the primary goals of doing bisulfite sequencing.  
 
We will first discuss the methods for identifying DMCs. Differential DNA methylation is usually 
calculated by comparing the proportion of methylated Cs in a test sample relative to a control. In 
simple comparisons between such pairs of samples (i.e. test and control), methods such as 
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Fisher’s Exact Test (implemented in methylkit ​[41]​, RnBeads ​[42]​ along with many other tools) 
can be applied when there are no replicates for test and control cases. There are also methods 
based on hidden Markov models (HMMs) such as ComMet, included in the Bisulfighter 
methylation analysis suite ​[43,44]​. These tools are sufficient to compare one test and one 
control sample at a time and if there are replicates; replicates can be pooled within groups to a 
single sample per group ​[41]​. This strategy, however, does not take into account biological 
variability between replicates. 
 
Regression based methods are generally used to model methylation levels in relation to the 
sample groups and variation between replicates. Differences between currently available 
regression methods stem from the choice of distribution to model the data and the variation 
associated with it. In the simplest case linear regression can be used to model methylation per 
given CpG or loci across sample groups. The model fits regression coefficients to model the 
expected methylation proportion values for each CpG site across sample groups. Following that, 
the null hypothesis of the model coefficients being zero could be tested using t-statistics. Such 
models are available in the limma package ​[45]​. Limma was initially developed for the detection 
of differential gene expression in microarray data, but it is also used for methylation data. It is 
the default method applied in RnBeads ​[46]​. It uses moderated t-statistics in which standard 
errors have been moderated across loci, i.e. shrunk towards a common value using Empirical 
Bayes method. Another method that relies on linear regression and t-test is BSmooth ​[47] 
method. The main difference is that BSmooth applies a local likelihood smoother to smooth the 
DNA methylation across CpGs within genomic windows, assumes that data follow a binomial 
distribution and parameters are estimated by fitting linear model inside windows. It calculates 
signal-to-noise ratio statistic similar to t-test together with Empirical Bayes approach to test the 
difference for each CpG.  
 
However, linear regression based methods might produce fitted methylation levels outside the 
range [0, 1] unless values are transformed before regression. An alternative is logistic 
regression which can deal with data strictly bounded between 0 and 1 and with non-constant 
variance, such as methylation proportion/fraction values. In the logistic regression, it is assumed 
that fitted values have variation ​np(1-p)​ , where ​p​  is the fitted methylation proportion for a given 
sample and ​n​  is the read coverage. If observed variance is larger or smaller than assumed by 
the model, one speaks of under or overdispersion. This over/under-dispersion can be corrected 
by calculating a scaling factor and using that factor to adjust the variance estimates as in 
np(1-p)s, ​ where ​s ​ is the scaling factor. methylKit package ​[41]​ can apply logistic regression to 
test the methylation difference with or without the overdispersion correction. In this case, 
Chi-square or F test can be used to compare the difference in the deviances of the null model 
and the alternative model. Null model assumes there is no relationship between sample groups 
and the methylation, and the alternative model assumes that there is a relationship where 
sample groups are predictive of methylation values for a given CpG or region for which the 
model is constructed. 
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More complex regression models use beta binomial distribution and they are particularly useful 
for better modeling the variance. Similar to logistic regression their observation follow binomial 
distribution (number of reads), but methylation proportion itself can vary across samples, 
according to a beta distribution. It can deal with fitting values in [0,1] range and performs better 
when there is more variance than expected by the simple logistic model. In essence, these 
models have a different way of calculating a scaling factor when there is overdispersion in the 
model. Further enhancements are made to these models by using the Empirical Bayes methods 
that can better estimate hyperparameters of beta distribution (variance-related parameters) by 
borrowing information between loci or regions within the genome to aid with inference about 
each individual loci or region. Some of the tools that rely on beta-binomial or beta model are as 
follows: MOABS ​[48]​ and DSS ​[49]​, RADMeth ​[50]​, BiSeq ​[48,51]​ and methylSig ​[52]​. 
  
The choice of the which method to apply also depends on the data at hand. If one do not have 
replicates, the choice of tests are Fisher’s Exact test (implemented in e.g. methylKit and 
RnBeads) or HMM-based methods such as comMet. If there are replicates tests based on 
regression are the natural choice rather than pooling the sample groups. Regression methods 
also have an advantage that one can add covariates into the tests such as technical/batch 
effects effects, age, sex, cell type heterogeneity, genetic effects. For instance, it has been 
shown that age is a contributing factor for methylation values at some CpGs ​[53,54]​ and genetic 
heritability ​[55]​. Covariates can be added to many methods such as methylKit, DSS, BSmooth 
and RnBeads.  
 
The performance of various differential methylation methods are not very different and each 
method has its own advantages and disadvantages. To show this, we compared three classes 
of methods: 1) t-test/linear regression, 2) logistic regression and 3) beta binomial regression. 
For comparisons, we used both a simulated data set and biologically relevant data set where we 
expect differentially methylated bases in certain regions. For the simulated data set, we used 
three different tools: DSS (beta binomial regression), limma (linear regression), and methylKit 
(logistic regression with/without overdispersion correction). We simulated a dataset consisting of 
6 samples (3 controls and 3 samples with treatment). The read coverage modeled by a binomial 
distribution. The methylation background followed a beta distribution with parameters alpha=0.4, 
beta=0.5 and theta=10. We simulated 5 sets of 5000 CpG sites where methylation at 50% of the 
sites was affected by the treatment to varying degrees - specifically, methylation was elevated 
by 5%, 10%, 15%, 20% and 25% in the test sample respectively in each set. To adjust p-values 
for multiple testing, we used q-value method ​[56]​ and we defined differentially methylated CpG 
sites with q-values below 0.01 for all examined methods. We calculated sensitivity, specificity 
and F-score for each of the three methods above. F-score refers to a way to measure sensitivity 
and specificity by calculating their harmonic mean. Limma  detected the fewest DMCs and 
consequently number of true positives which leaded to the lowest sensitivity (see Figure 2). 
DSS had similar results to limma where both also have high specificity. MethylKit also 
performed well using either the Chi-squared or F test. MethylKit without overdispersion showed 
the lowest specificity. The overdispersion correction usually improves specificity. F-test with 
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overdispersion has similar results to DSS, whereas Chi-squared test with overdispersion 
correction has similar specificity to stringent methods such as DSS and limma but achieves 
higher sensitivity. In addition, higher effect sizes results in higher sensitivity for all methods. 
Researchers should also consider a cutoff for the effect size or methylation difference in their 
analyses, as it is easier to detect changes with higher effect sizes but also smaller effect sizes 
may not be biologically meaningful. 5% change in methylation may not have an equivalent effect 
on gene expression and small changes may be within the range of the acceptable noise for 
biological systems.  
 
Performance of different methods using simulated datasets are always a subject of debate. 
There are many different ways to simulate datasets and how the data is simulated can bias the 
performance metrics towards certain methods. Therefore, we also compared the performance of 
different methods using real bisulfite-sequencing experiments where we expect to see changes 
between samples on certain locations. Stadler and colleagues showed that DNA-binding factors 
can to create low-methylated regions upon binding ​[12]​. They further show that the reduced 
methylation is a general feature of CTCF-occupied sites and if the site is unoccupied, the region 
on and around the site will have high methylation. This means that if the CTCF occupancy 
changes between two cell types, we expect to see a change in the methylation levels as well. 
Armed with this information, we looked for differentially methylated bases on regions that gained 
or lost CTCF binding between two cell types. We used the CTCF occupancy, binarized as peak 
present or peak lost, and the ENCODE RRBS data (where each cell line has two replicates) for 
19 human cell lines ​[57]​. We performed pairwise comparisons for each pair in all possible 
combinations of these 19 cell lines. We defined true positives as the number of CTCF peaks 
gained/lost between two cell lines which overlap at least one DMC. True negatives are defined 
as the number of CTCF peaks that do not change between cell lines and do not overlap any 
DMC although they are covered by RRBS reads. Accordingly, false positives are defined as the 
number of CTCF peaks that are present in both cell lines but overlap with at least one DMC, 
while false negatives are defined as peaks that are gained or lost between cell lines but have no 
DMC. We also down-sampled the CTCF peaks that do not change to match the number of 
peaks that change, to have a balanced classification performance, otherwise true negatives 
overwhelm performance metrics since there are many CTCF peaks that do not change. 
Differentially methylated CpGs were identified for all combinations of two cell lines using DSS, 
limma, methylKit and BSmooth. In the simulation data set, we did not model changes in 
methylation of nearby CpGs and since BSmooth assumes that the true methylation profile is 
smooth and uses a local smoother, it was not adequate to apply this method on simulation data 
and did not perform well.  
 
For the CTCF dataset, we observed consistent results with the simulated dataset results (Figure 
3). limma has the highest specificity, however it detects extremely small number of true positives 
and has the lowest sensitivity. MethylKit without overdispersion had the highest F-score, but 
also the lowest specificity. With overdispersion, methylKit showed higher specificity close to 
DSS and BSmooth and second highest F-score. Taken together with the simulation results, 
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methylKit without overdispersion can be used for more exploratory analysis as it achieves 
higher sensitivity but lower specificity, although it is still the best method when overall accuracy 
is considered. In contrast limma, DSS and methylKit F test with overdispersion correction can be 
applied when there is a need to limit false positive rates, such as when picking regions or CpGs 
for validation. A good compromise between stringent and relaxed methods seems to be 
Chi-squared test with overdispersion correction.  
 
 
 
Defining differentially methylated regions 
Most of the methods for differential methylation calling discussed earlier are designed to 
calculate both DMCs and DMRs. Some of them are designed to detect DMRs via aggregating 
DMC together within a predefined regions, such as CpG islands or CpG shores. RADmeth ​[50] 
and eDMR ​[58]​ groups P-values of adjacent CpGs and produce differentially methylated regions 
based on distance between differential CpGs and combination of their P-values using weighted 
Z-test. DSS set some thresholds on the P-values, number of CpG sites and length of regions 
before aggregation. Similarly, BSmooth defines DMRs by taking consecutive CpGs and cutoff 
based on the marginal empirical distribution of t and DMRs are ranked by sum of t-statistics in 
each CpG. BiSeq, on the other hand, first agglomerates CpG sites into clusters and smoothes 
methylation within clusters, uses beta regression and Wald test to test a group effect between 
control and test samples (with maximum likelihood with bias reduction). Apart from the various 
ways of clustering nearby CpGs or DMCs, many other methods rely on HMMs or other 
segmentation methods to segment the differential CpGs into hypo- and hyper-methylated 
regions and combine them to DMRs, such as MOABS, Methpipe, ComMet and methylKit.  
 
Other methods define DMRs directly based on pre-defined windows. When input for functions 
for differential methylation calling are regions, so then data is summarized per region. The 
regions can be either predefined (such as regions with biological meaning like CpG islands) or 
use-defined with criteria like fixed region length for tilling windows that cover the whole genome, 
fixed numbers of significant adjacent CpG sites and smoothed estimated effect sizes.  
 
Segmentation of the methylome 
The analysis of methylation dynamics is not only restricted to differentially methylated regions 
across samples, apart from this there is also an interest in examining the methylation profiles 
within the same sample. Usually depressions in methylation profiles pinpoint regulatory regions 
like gene promoters that co-localize with CG-dense CpG islands. On the other hand many 
gene-body regions are extensively methylated and CpG-poor ​[1]​. These observations would 
describe a bimodal model of either hyper- or hypomethylated regions dependent on the local 
density of CpGs ​[59]​. However, with the detection of CpG-poor regions with locally reduced 
levels of methylation ( on average 30 % ) in pluripotent embryonic stem cells and in neuronal 
progenitors in both mouse and human a different model seems also reasonable ​[12]​. These 
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low-methylated regions (LMRs) are located distal to promoters, have little overlap with CpG 
islands and associated with enhancer marks such as p300 binding sites and H3K27ac 
enrichment.  
 
The identification of these LMRs can be achieved by segmentation of the methylome using 
computational approaches. One of the well-known segmentation methods is based on a three 
state Hidden Markov Model (HMM) taking only DNA methylation into account, without 
knowledge of any additional genomic information such as CpG density or functional annotations 
[12]​. The three states that the  authors aimed for were fully methylated regions (FMRs), 
unmethylated regions (UMRs) and low-methylated regions (LMRs). This segmentation 
represents a summary of methylome properties and features, in which unmethylated CpG 
islands correspond to UMRs ​[5]​, the majority is classified as FMR since most of the genome is 
methylated ​[60]​ and LMRs represent a new feature with intermediate levels of methylation,  poor 
CpG content and  shorter length compared to CpG islands ​[12]​. Other segmentation methods 
such as methPipe assume a two model state HMM and can not differentiate between LMRs and 
UMRs.  
 
The authors of the R package “​MethylSeekR​” ​[61]​ adapt the idea of a three feature methylome 
and additionally identify partially methylated domains (PMDs), another methylome feature found 
for instance in human fibroblast but not in H1 embryonic stem cells ​[2,62]​. These large regions 
(mean length = 153 kb) are characterized by highly disordered methylation with average levels 
of methylation below 70% and covering almost 40% of the genome ​[2,62]​. PMDs do not 
necessarily occur in every methylome, but they are detected using a sliding window statistic and 
genome wide identified with a HMM, as they need to be masked prior the characterization of 
UMRs / LMRs ​[61]​. 
 
There are also other segmentation strategies based on change-point analysis, where 
change-points of a genome wide signal are recorded and the genome is partitioned into regions 
between consecutive change points. This approach is typically used in the context of copy 
number variation detection ​[63]​ but can be applied to methylome segmentation as well.  
A package implementing this method of segmentation based on change points is methylKit, 
where the identified segments are further clustered using a mixture modeling approach. This 
clustering is based only on the average methylation level of the segments and allows the 
detection of distinct methylome features comparable to UMRs, LMRs and FMRs. This approach 
provides a more robust approach to segmentation where one can decide number of segment 
classes after segmentation whereas in HMM based methods one must know apriori number of 
segment classes or run multiple rounds HMMs with different numbers and identify which model 
fits better to the data.  
 
Comparison of segmentation methods 
We compared the change-point based segmentation to MethylSeekR, which is partially based 
on HMMs and but mainly using cutoffs for methylation values. We identified high-concordance 
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between the two methods analysing the H1 embryonic stem cells methylome from the roadmap 
epigenomics project ​[64]​. They describe regions with similar methylation values, segment 
lengths and genome annotation (Figure 4). 
 
We also applied change-point based segmentation to a genome with PMDs. We segmented the 
Human IMR90 methylome into four distinct features (Figure 5). We selected the feature with 
mean methylation level of segments closest to 50% to compare it to published PMDs ​[2,62]​. We 
overlapped all segments of this feature with the published regions and found that 81% of the 
generated segments of our feature overlap with the published regions of PMDs. Change-point 
based segmentation methods can also identify PMDs. 
 
 
Strategies for dealing with large datasets 
With rising numbers of publicly available epigenetic data we are tempted to reconstruct the 
results of published papers for many reasons, e.g. to better understand the reasoning behind 
steps the authors took or to get a general feeling for the data.  In case of bisulfite sequencing 
data we might want to perform differential methylation analysis in R using whole genome 
methylation data of multiple samples. The problem is that for genome wide experiments ​file 
sizes can easily range from hundreds of megabytes to gigabytes and processing multiple 
instances of those files in memory (RAM) might become infeasible unless we have access to a 
high performance cluster (HPC) with lots of RAM. If we want to use a desktop computer or 
laptop with limited amount of RAM we either need to restrict our analysis on a subset of the data 
or use packages that can handle this situation.  
 
The authors of the RADmeth package for differential methylation analysis advise to run the 
software on a “computing cluster with a few hundred available nodes” to allow the processing of 
multiple WGBS samples in reasonable time. The same analysis can as well be performed on a 
personal workstation with the disadvantage of increasing of computational time, which is in 
general dependent on three factors: the sample coverage, the number of sites analyzed and the 
number of samples. There exists one opportunity to speed up the time consuming regression 
step if your workstation is a multicore system. The authors included a script to split the input 
data into smaller pieces which could than be processed separately and merged afterwards 
using UNIX commands.  
 
A package for the comprehensive analysis of genome-wide DNA methylation data that can 
handle large data is RnBeads ​[42]​, which internally relies on the ‘ff’ package. The R package ‘ff’ 
[65]​ allows the work with datasets larger than available RAM by storing them as temporary files 
and providing an interface to enable reading and writing from flat files and operate on the parts 
that have been loaded into R. 
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The methylKit package provides very similar capability by exploiting flat file databases to 
substitute in-memory objects if the objects grow too large. The internal data apart from meta 
information has a tabular structure storing chromosome, start/end position, strand information of 
the associated CpG base just like many other biological formats like BED, GFF or SAM. By 
exporting this tabular data into a TAB-delimited file and making sure it is accordingly position 
sorted it can be indexed using the generic Tabix tool ​[66]​. In general “Tabix indexing is a 
generalization of BAM indexing for generic TAB-delimited files. It inherits all the advantages of 
BAM indexing, including data compression and efficient random access in terms of few seek 
function calls per query.” ​[66]​. MethylKit relies on Rsamtools 
(​http://bioconductor.org/packages/release/bioc/html/Rsamtools.html ​) which implements tabix 
functionality for R and this way internal methylKit objects can be efficiently stored as 
compressed file on the disk and still be fast accessed. Another advantage is that compressed 
files formerly created can be actually loaded in interactive sessions, allowing the backup and 
transfer of intermediate analysis results.  
 
 
 
Annotation of DMRs/DMCs and segments  
The regions of interest obtained through differential methylation or segmentation analysis often 
needs to be integrated with genome annotation datasets. Without this type of integration, 
differential methylation or segmentation results will be hard to interpret in terms of biology. The 
most common annotation task is to see where regions of interest land in relation to genes and 
gene parts and regulatory regions: Do they mostly occupy promoter, intronic or exonic regions ? 
Do they overlap with repeats ? Do they overlap with other epigenomic markers or long-range 
regulatory regions ? These questions are not specific to methylation, nearly all regions of 
interest obtained via genome-wide studies have to deal with such questions. There are multiple 
software tools that can produce such annotations. One is Bioconductor package genomation 
[67]​. It can be used to annotate DMRs/DMCs and it can also be used to integrate methylation 
proportions over the genome with other quantitative information and produce meta-gene plots or 
heatmaps. Another similar package is ChIPpeakAnno ​[68]​, which is designed for ChIP-seq peak 
annotation but could be used for DMR/DMC annotation to a certain degree. 
 
 
Workflows and tools that do not require programming experience  
Software packages for the analysis of whole genome bisulfite sequencing data perform 
computationally intensive tasks and are therefore hosted on advanced hardware infrastructures. 
Moreover, the majority of the tools require programming knowledge (e.g. writing R commands). 
If the local execution of those tools is not feasible due to insufficient processing power or 
expertise, using an online service could be an alternative. For example, an analysis workflow on 
the RnBeads web service is started by simply uploading the data and setting a handful of 
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options through a web form. The limitations it imposes on file size, however, make it infeasible 
for large datasets. Galaxy is an open source, web-based platform for data intensive biomedical 
research (see ​https://galaxyproject.org​), providing access to publicly available servers and tools 
dedicated to data processing and analysis. A curated list of tools exists at 
https://toolshed.g2.bx.psu.edu​ hosting 4300 different programs for use within Galaxy at the time 
of writing, including methylKit 
https://toolshed.g2.bx.psu.edu/view/rnateam/methylkit/a8705df7c57f​) and RnBeads 
(​https://toolshed.g2.bx.psu.edu/view/pavlo-lutsik/rnbeads/6b0981ab063e​). 
WBSA is another freely available  web service for WGBS and RRBS 1
(​http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086707​) data. It is a modular 
collection of custom scripts combined with widely used tools, such as BWA for alignment and 
FastQC for quality control. The focus of WBSA is on ease of use. Uploading data and setting up 
analysis parameters is achieved using a small web form. The main advantages of this service 
are support for genome assemblies from 10 species, support for a range of sequencing 
protocols, as well as extraction and analysis of non-CpG methylation. More flexibility can be 
achieved by downloading and locally installing the modules, however, installing the WBSA 
back-end is a non-trivial task as its long list of dependencies includes tools and libraries from 
heterogeneous platforms: Java, MySQL, Perl, and R. 
 
Conclusions 
In this review, we have discussed the experimental and the computational methods to measure 
and computationally analyse DNA methylation in genome-wide or targeted manner. We 
presented all the necessary steps of downstream analysis for bisulfite sequencing experiments 
starting from read alignment and quality check. We discussed and compared differential 
methylation and methylome segmentation methods. Our efforts for comparing differential 
methylation methods revealed that performances of different methods are comparable. One can 
choose methods based on the overall goal of their research. The methods that are stringent and 
limit the false positive rates are good for subsequent validation studies (DSS, limma, BSmooth, 
MethylKit with F test and overdispersion correction), however these methods sacrifice sensitivity 
(true positive rate) for sake of reducing false positives. A very relaxed method, such as default 
methylKit method, has the best accuracy overall but highest false positive rate. A good 
alternative to stringent and relaxed methods is Chi-square test after overdispersion correction 
(implemented in methylKit). This method has high sensitivity without sacrificing too much for 
specificity. For segmentation methods, we observed high-concordance between cutoff based 
methods and change-point analysis based methods. Change-point analysis methods are more 
flexible in the sense that they identify multiple biologically relevant segments within the same 
analysis. For example, HMM or cutoff based methods should first remove partially methylated 
1 for academic use only 
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domains (PMDs) from the analysis in order to define LMRs. Whereas change-point analysis 
based methods can identify LMRs and PMDs in the same analysis. 
 
We believe through this guideline of methods for BS-seq analysis both bioinformaticians as well 
as experimental biologists will gain idea not only about experimental design, but also best 
practises for computational analysis. 
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Figure 1. Workflow for analysis of DNA methylation using data from bisulfite sequencing 
experiments. 
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Figure 2. Comparison of DMC detection methods on simulated data. Barplots show sensitivity 
(a), specificity (b) and F-score (c) using DSS, limma, methylKit with Chi-squared or F test. 
Overdispersion correction available only for methylKit has suffix “-OC”. Effect size indicates 
methylation differences between two groups of samples. Replicates in one group had elevated 
methylation in 50% of CpGs sites by accordingly 5%, 10%, 15%, 20% and 25%. 
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Figure 3. Performance measurements of tools for DMCs detection based on the association 
between CTCF occupancy with methylation status in cell-type specific manner using the Wang 
et al data. Bars indicate performance BSmooth, DSS, limma, methylKit between pairs of multiple 
cell lines. MethylKit was performed using Chi-squared and F-test. MethylKit with overdispersion 
corrected is depicted with “-OC” suffix. 
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Figure 4. Comparison of features identified by segmentation tools analysing the H1 embryonic 
stem cells methylome. Boxplots show for each feature the distribution of (a) segment lengths in 
log10 transformed base pairs (bp)  (b) CpG position covered by each segment in log10 
transformed numbers (c) average methylation score per segment. (a) - (c) Boxplot colors 
indicate the tool generating the features either methylKit or MethylSeekR.  
(d) Heatmap showing the percentage of methylSeeker and methylKit segments that overlapped 
with chromatin state annotations for H1 embryonic stem cells.  
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Figure 5. Boxplot showing the distribution of average methylation score per segment class 
analysing Human IMR90 methylome using methylKit change-point based segmentation. 
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